The occurrence rate of BRAF fusions is smaller than 1% in NSCLC, and all NSCLCs with BRAF fusions were adenocarcinomas or NSCLC with adenocarcinoma features. This evidence concerns the gene BRAF and non-small cell lung carcinoma.